Lu Jun, Wang Da-Ming, Chen Hai-Bo, Liu Jia-Chun, Liu Fang, Jiang Hong-Zhi, Li Jin, Wang Li-Jun, Gong Tao, Jiang Xue-Li, Zhai Le-Le
Department of Neurosurgery, Beijing Hospital, Beijing 100730, China.
Zhonghua Wai Ke Za Zhi. 2007 Feb 15;45(4):226-9.
To evaluate the feasibility, safety and short-term efficacy of stent-assisted angioplasty and/or drug therapy for elderly patients with symptomatic vertebrobasilar insufficiency.
Elderly patients (> or = 60 years old) with symptomatic vertebrobasilar stenosis (> or = 50%) demonstrated by cerebral angiography were treated with drug therapy and some with endovascular stenting further from April 2001 to June 2006. The clinical, imaging, intervention and follow-up data were collected and analyzed.
Eighty-one elderly patients were chosen for study, including 68 males and 13 females. The mean age is 70 years (60 - 87 years); stroke rate of 4.9% (4/81) and stroke-related mortality rate of 2.5% (2/81) were found in this group during hospitalization and follow-up (mean 28.1 months), and symptoms resolved or improved clinically in 66 (81.5%). Fifty-two balloon expandable stents were placed in 48 (59.3%) patients of this group with a technical success rate of 98.1% and the mean degree of stenosis was reduced from (82.4 +/- 13.1)% to (6.4 +/- 3.2)% (t = 22.4, P = 0.00).
Appropriate management including endovascular stenting and/or drug therapy may improve short-term outcomes of elderly patients with symptomatic vertebrobasilar insufficiency; meanwhile, stent-assisted angioplasty is technically feasible and relatively safe.
评估支架辅助血管成形术和/或药物治疗对有症状的老年椎基底动脉供血不足患者的可行性、安全性及短期疗效。
选取2001年4月至2006年6月期间经脑血管造影证实有症状的椎基底动脉狭窄(≥50%)的老年患者(≥60岁),先给予药物治疗,部分患者进一步行血管内支架置入术。收集并分析临床、影像学、干预及随访数据。
选取81例老年患者进行研究,其中男性68例,女性13例。平均年龄70岁(60 - 87岁);该组患者在住院及随访期间(平均28.1个月)的卒中发生率为4.9%(4/81),卒中相关死亡率为2.5%(2/81),66例(81.5%)患者的症状在临床上得到缓解或改善。该组48例(59.3%)患者置入了52枚球囊扩张支架,技术成功率为98.1%,平均狭窄程度从(82.4±13.1)%降至(6.4±3.2)%(t = 22.4,P = 0.00)。
包括血管内支架置入术和/或药物治疗在内的适当治疗可能改善有症状的老年椎基底动脉供血不足患者的短期预后;同时,支架辅助血管成形术在技术上可行且相对安全。